In 2010 a major rally broke loose when 3M was initiating an MTA...

In 2010 a major rally broke loose when 3M was initiating an MTA with OBJ.


In 2012, we have an EXCLUSIVE development agreement with the world' largest FMCG, P&G, new active successes with GSK ( finally in black in white that in vivo testing cycles went very well ), oral health developments with GSK and
now Pfizer as well.

Pfizer collaborating with OBJ would have sent the shareprice ballistic in 2010.
What has changed?


I believe the market has turned numb towards OBJ, not properly digesting information provided, ignoring outlook.
PRR was a good example in the past how this ignorance can go on for quite some time until panic breaks out not to miss the boat.


When GSK, P&G AND Pfizer colloborate in development agreements, two of them exclusively, something has to be up.
The often quoted argument that those globals have many collaboration agreements in place means very little when those 3 companies do have development agreements in place simultaneously.



I'm not surprised that we saw some buying straight after the AGM.

This current presentation also puts our own product developments in a proper light in regards to CRs.
OBJ would not advertise its own developments at such length if they would plan to raise money.
It would simply be the wrong way forward, instead they would concentrate on partner activities to attempt to raise the price prior to the issue.



This latest presentation puts in perspective for me the immediate share price appreciation I do expect.